Global Swine Mycoplasma Pneumonia Live Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Swine Mycoplasma Pneumonia Live Vaccine market size was valued at USD 220.2 million in 2022 and is forecast to a readjusted size of USD 329.6 million by 2029 with a CAGR of 5.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Swine Mycoplasma Pneumonia Live Vaccine is a vaccine used to prevent respiratory diseases caused by Mycoplasma hyopneumoniae in pigs. This vaccine is a live attenuated vaccine that helps to stimulate the pig's immune system to recognize and fight against the bacteria that causes pneumonia.
This report is a detailed and comprehensive analysis for global Swine Mycoplasma Pneumonia Live Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Swine Mycoplasma Pneumonia Live Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Swine Mycoplasma Pneumonia Live Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Swine Mycoplasma Pneumonia Live Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Swine Mycoplasma Pneumonia Live Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Swine Mycoplasma Pneumonia Live Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Swine Mycoplasma Pneumonia Live Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis, Boehringer Ingelheim, Merck, HIPRA and Ceva Sant? Animale, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Swine Mycoplasma Pneumonia Live Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Swine Mycoplasma Pneumonia Live Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Swine Mycoplasma Pneumonia Live Vaccine, with price, sales, revenue and global market share of Swine Mycoplasma Pneumonia Live Vaccine from 2018 to 2023.
Chapter 3, the Swine Mycoplasma Pneumonia Live Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Swine Mycoplasma Pneumonia Live Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Swine Mycoplasma Pneumonia Live Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Swine Mycoplasma Pneumonia Live Vaccine.
Chapter 14 and 15, to describe Swine Mycoplasma Pneumonia Live Vaccine sales channel, distributors, customers, research findings and conclusion.
Swine Mycoplasma Pneumonia Live Vaccine is a vaccine used to prevent respiratory diseases caused by Mycoplasma hyopneumoniae in pigs. This vaccine is a live attenuated vaccine that helps to stimulate the pig's immune system to recognize and fight against the bacteria that causes pneumonia.
This report is a detailed and comprehensive analysis for global Swine Mycoplasma Pneumonia Live Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Swine Mycoplasma Pneumonia Live Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Swine Mycoplasma Pneumonia Live Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Swine Mycoplasma Pneumonia Live Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Swine Mycoplasma Pneumonia Live Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Swine Mycoplasma Pneumonia Live Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Swine Mycoplasma Pneumonia Live Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis, Boehringer Ingelheim, Merck, HIPRA and Ceva Sant? Animale, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Swine Mycoplasma Pneumonia Live Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- 168 Strains
- RM48 Strains
- Other
- Piglets
- Adult Pigs
- Zoetis
- Boehringer Ingelheim
- Merck
- HIPRA
- Ceva Sant? Animale
- Harbin Pharmaceutical Group
- Qilu Animal Health Products
- Guangdong Winsun Bio-Pharmaceutical
- Jilin HeYuan Bioengineering
- Jofunhwa Biotechnology
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Swine Mycoplasma Pneumonia Live Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Swine Mycoplasma Pneumonia Live Vaccine, with price, sales, revenue and global market share of Swine Mycoplasma Pneumonia Live Vaccine from 2018 to 2023.
Chapter 3, the Swine Mycoplasma Pneumonia Live Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Swine Mycoplasma Pneumonia Live Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Swine Mycoplasma Pneumonia Live Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Swine Mycoplasma Pneumonia Live Vaccine.
Chapter 14 and 15, to describe Swine Mycoplasma Pneumonia Live Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Swine Mycoplasma Pneumonia Live Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 168 Strains
1.3.3 RM48 Strains
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Piglets
1.4.3 Adult Pigs
1.5 Global Swine Mycoplasma Pneumonia Live Vaccine Market Size & Forecast
1.5.1 Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity (2018-2029)
1.5.3 Global Swine Mycoplasma Pneumonia Live Vaccine Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Zoetis
2.1.1 Zoetis Details
2.1.2 Zoetis Major Business
2.1.3 Zoetis Swine Mycoplasma Pneumonia Live Vaccine Product and Services
2.1.4 Zoetis Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Zoetis Recent Developments/Updates
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Product and Services
2.2.4 Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Boehringer Ingelheim Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Swine Mycoplasma Pneumonia Live Vaccine Product and Services
2.3.4 Merck Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Merck Recent Developments/Updates
2.4 HIPRA
2.4.1 HIPRA Details
2.4.2 HIPRA Major Business
2.4.3 HIPRA Swine Mycoplasma Pneumonia Live Vaccine Product and Services
2.4.4 HIPRA Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 HIPRA Recent Developments/Updates
2.5 Ceva Sant? Animale
2.5.1 Ceva Sant? Animale Details
2.5.2 Ceva Sant? Animale Major Business
2.5.3 Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Product and Services
2.5.4 Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Ceva Sant? Animale Recent Developments/Updates
2.6 Harbin Pharmaceutical Group
2.6.1 Harbin Pharmaceutical Group Details
2.6.2 Harbin Pharmaceutical Group Major Business
2.6.3 Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Product and Services
2.6.4 Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Harbin Pharmaceutical Group Recent Developments/Updates
2.7 Qilu Animal Health Products
2.7.1 Qilu Animal Health Products Details
2.7.2 Qilu Animal Health Products Major Business
2.7.3 Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Product and Services
2.7.4 Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Qilu Animal Health Products Recent Developments/Updates
2.8 Guangdong Winsun Bio-Pharmaceutical
2.8.1 Guangdong Winsun Bio-Pharmaceutical Details
2.8.2 Guangdong Winsun Bio-Pharmaceutical Major Business
2.8.3 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Product and Services
2.8.4 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Guangdong Winsun Bio-Pharmaceutical Recent Developments/Updates
2.9 Jilin HeYuan Bioengineering
2.9.1 Jilin HeYuan Bioengineering Details
2.9.2 Jilin HeYuan Bioengineering Major Business
2.9.3 Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Product and Services
2.9.4 Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Jilin HeYuan Bioengineering Recent Developments/Updates
2.10 Jofunhwa Biotechnology
2.10.1 Jofunhwa Biotechnology Details
2.10.2 Jofunhwa Biotechnology Major Business
2.10.3 Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Product and Services
2.10.4 Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Jofunhwa Biotechnology Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: SWINE MYCOPLASMA PNEUMONIA LIVE VACCINE BY MANUFACTURER
3.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Swine Mycoplasma Pneumonia Live Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Swine Mycoplasma Pneumonia Live Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Swine Mycoplasma Pneumonia Live Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Swine Mycoplasma Pneumonia Live Vaccine Manufacturer Market Share in 2022
3.5 Swine Mycoplasma Pneumonia Live Vaccine Market: Overall Company Footprint Analysis
3.5.1 Swine Mycoplasma Pneumonia Live Vaccine Market: Region Footprint
3.5.2 Swine Mycoplasma Pneumonia Live Vaccine Market: Company Product Type Footprint
3.5.3 Swine Mycoplasma Pneumonia Live Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Swine Mycoplasma Pneumonia Live Vaccine Market Size by Region
4.1.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Region (2018-2029)
4.2 North America Swine Mycoplasma Pneumonia Live Vaccine Consumption Value (2018-2029)
4.3 Europe Swine Mycoplasma Pneumonia Live Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Consumption Value (2018-2029)
4.5 South America Swine Mycoplasma Pneumonia Live Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Swine Mycoplasma Pneumonia Live Vaccine Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Type (2018-2029)
5.3 Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Application (2018-2029)
6.3 Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Swine Mycoplasma Pneumonia Live Vaccine Market Size by Country
7.3.1 North America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Swine Mycoplasma Pneumonia Live Vaccine Market Size by Country
8.3.1 Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Market Size by Region
9.3.1 Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Swine Mycoplasma Pneumonia Live Vaccine Market Size by Country
10.3.1 South America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Market Size by Country
11.3.1 Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Swine Mycoplasma Pneumonia Live Vaccine Market Drivers
12.2 Swine Mycoplasma Pneumonia Live Vaccine Market Restraints
12.3 Swine Mycoplasma Pneumonia Live Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Swine Mycoplasma Pneumonia Live Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Swine Mycoplasma Pneumonia Live Vaccine
13.3 Swine Mycoplasma Pneumonia Live Vaccine Production Process
13.4 Swine Mycoplasma Pneumonia Live Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Swine Mycoplasma Pneumonia Live Vaccine Typical Distributors
14.3 Swine Mycoplasma Pneumonia Live Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Swine Mycoplasma Pneumonia Live Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 168 Strains
1.3.3 RM48 Strains
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Piglets
1.4.3 Adult Pigs
1.5 Global Swine Mycoplasma Pneumonia Live Vaccine Market Size & Forecast
1.5.1 Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity (2018-2029)
1.5.3 Global Swine Mycoplasma Pneumonia Live Vaccine Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Zoetis
2.1.1 Zoetis Details
2.1.2 Zoetis Major Business
2.1.3 Zoetis Swine Mycoplasma Pneumonia Live Vaccine Product and Services
2.1.4 Zoetis Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Zoetis Recent Developments/Updates
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Product and Services
2.2.4 Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Boehringer Ingelheim Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Swine Mycoplasma Pneumonia Live Vaccine Product and Services
2.3.4 Merck Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Merck Recent Developments/Updates
2.4 HIPRA
2.4.1 HIPRA Details
2.4.2 HIPRA Major Business
2.4.3 HIPRA Swine Mycoplasma Pneumonia Live Vaccine Product and Services
2.4.4 HIPRA Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 HIPRA Recent Developments/Updates
2.5 Ceva Sant? Animale
2.5.1 Ceva Sant? Animale Details
2.5.2 Ceva Sant? Animale Major Business
2.5.3 Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Product and Services
2.5.4 Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Ceva Sant? Animale Recent Developments/Updates
2.6 Harbin Pharmaceutical Group
2.6.1 Harbin Pharmaceutical Group Details
2.6.2 Harbin Pharmaceutical Group Major Business
2.6.3 Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Product and Services
2.6.4 Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Harbin Pharmaceutical Group Recent Developments/Updates
2.7 Qilu Animal Health Products
2.7.1 Qilu Animal Health Products Details
2.7.2 Qilu Animal Health Products Major Business
2.7.3 Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Product and Services
2.7.4 Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Qilu Animal Health Products Recent Developments/Updates
2.8 Guangdong Winsun Bio-Pharmaceutical
2.8.1 Guangdong Winsun Bio-Pharmaceutical Details
2.8.2 Guangdong Winsun Bio-Pharmaceutical Major Business
2.8.3 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Product and Services
2.8.4 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Guangdong Winsun Bio-Pharmaceutical Recent Developments/Updates
2.9 Jilin HeYuan Bioengineering
2.9.1 Jilin HeYuan Bioengineering Details
2.9.2 Jilin HeYuan Bioengineering Major Business
2.9.3 Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Product and Services
2.9.4 Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Jilin HeYuan Bioengineering Recent Developments/Updates
2.10 Jofunhwa Biotechnology
2.10.1 Jofunhwa Biotechnology Details
2.10.2 Jofunhwa Biotechnology Major Business
2.10.3 Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Product and Services
2.10.4 Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Jofunhwa Biotechnology Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: SWINE MYCOPLASMA PNEUMONIA LIVE VACCINE BY MANUFACTURER
3.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Swine Mycoplasma Pneumonia Live Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Swine Mycoplasma Pneumonia Live Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Swine Mycoplasma Pneumonia Live Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Swine Mycoplasma Pneumonia Live Vaccine Manufacturer Market Share in 2022
3.5 Swine Mycoplasma Pneumonia Live Vaccine Market: Overall Company Footprint Analysis
3.5.1 Swine Mycoplasma Pneumonia Live Vaccine Market: Region Footprint
3.5.2 Swine Mycoplasma Pneumonia Live Vaccine Market: Company Product Type Footprint
3.5.3 Swine Mycoplasma Pneumonia Live Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Swine Mycoplasma Pneumonia Live Vaccine Market Size by Region
4.1.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Region (2018-2029)
4.2 North America Swine Mycoplasma Pneumonia Live Vaccine Consumption Value (2018-2029)
4.3 Europe Swine Mycoplasma Pneumonia Live Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Consumption Value (2018-2029)
4.5 South America Swine Mycoplasma Pneumonia Live Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Swine Mycoplasma Pneumonia Live Vaccine Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Type (2018-2029)
5.3 Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Application (2018-2029)
6.3 Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Swine Mycoplasma Pneumonia Live Vaccine Market Size by Country
7.3.1 North America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Swine Mycoplasma Pneumonia Live Vaccine Market Size by Country
8.3.1 Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Market Size by Region
9.3.1 Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Swine Mycoplasma Pneumonia Live Vaccine Market Size by Country
10.3.1 South America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Market Size by Country
11.3.1 Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Swine Mycoplasma Pneumonia Live Vaccine Market Drivers
12.2 Swine Mycoplasma Pneumonia Live Vaccine Market Restraints
12.3 Swine Mycoplasma Pneumonia Live Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Swine Mycoplasma Pneumonia Live Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Swine Mycoplasma Pneumonia Live Vaccine
13.3 Swine Mycoplasma Pneumonia Live Vaccine Production Process
13.4 Swine Mycoplasma Pneumonia Live Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Swine Mycoplasma Pneumonia Live Vaccine Typical Distributors
14.3 Swine Mycoplasma Pneumonia Live Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Zoetis Basic Information, Manufacturing Base and Competitors
Table 4. Zoetis Major Business
Table 5. Zoetis Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 6. Zoetis Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Zoetis Recent Developments/Updates
Table 8. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 9. Boehringer Ingelheim Major Business
Table 10. Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 11. Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Boehringer Ingelheim Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 16. Merck Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Merck Recent Developments/Updates
Table 18. HIPRA Basic Information, Manufacturing Base and Competitors
Table 19. HIPRA Major Business
Table 20. HIPRA Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 21. HIPRA Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. HIPRA Recent Developments/Updates
Table 23. Ceva Sant? Animale Basic Information, Manufacturing Base and Competitors
Table 24. Ceva Sant? Animale Major Business
Table 25. Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 26. Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Ceva Sant? Animale Recent Developments/Updates
Table 28. Harbin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 29. Harbin Pharmaceutical Group Major Business
Table 30. Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 31. Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Harbin Pharmaceutical Group Recent Developments/Updates
Table 33. Qilu Animal Health Products Basic Information, Manufacturing Base and Competitors
Table 34. Qilu Animal Health Products Major Business
Table 35. Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 36. Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Qilu Animal Health Products Recent Developments/Updates
Table 38. Guangdong Winsun Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Guangdong Winsun Bio-Pharmaceutical Major Business
Table 40. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 41. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Guangdong Winsun Bio-Pharmaceutical Recent Developments/Updates
Table 43. Jilin HeYuan Bioengineering Basic Information, Manufacturing Base and Competitors
Table 44. Jilin HeYuan Bioengineering Major Business
Table 45. Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 46. Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Jilin HeYuan Bioengineering Recent Developments/Updates
Table 48. Jofunhwa Biotechnology Basic Information, Manufacturing Base and Competitors
Table 49. Jofunhwa Biotechnology Major Business
Table 50. Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 51. Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Jofunhwa Biotechnology Recent Developments/Updates
Table 53. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Swine Mycoplasma Pneumonia Live Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Swine Mycoplasma Pneumonia Live Vaccine Production Site of Key Manufacturer
Table 58. Swine Mycoplasma Pneumonia Live Vaccine Market: Company Product Type Footprint
Table 59. Swine Mycoplasma Pneumonia Live Vaccine Market: Company Product Application Footprint
Table 60. Swine Mycoplasma Pneumonia Live Vaccine New Market Entrants and Barriers to Market Entry
Table 61. Swine Mycoplasma Pneumonia Live Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Swine Mycoplasma Pneumonia Live Vaccine Raw Material
Table 121. Key Manufacturers of Swine Mycoplasma Pneumonia Live Vaccine Raw Materials
Table 122. Swine Mycoplasma Pneumonia Live Vaccine Typical Distributors
Table 123. Swine Mycoplasma Pneumonia Live Vaccine Typical Customers
Table 1. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Zoetis Basic Information, Manufacturing Base and Competitors
Table 4. Zoetis Major Business
Table 5. Zoetis Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 6. Zoetis Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Zoetis Recent Developments/Updates
Table 8. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 9. Boehringer Ingelheim Major Business
Table 10. Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 11. Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Boehringer Ingelheim Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 16. Merck Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Merck Recent Developments/Updates
Table 18. HIPRA Basic Information, Manufacturing Base and Competitors
Table 19. HIPRA Major Business
Table 20. HIPRA Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 21. HIPRA Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. HIPRA Recent Developments/Updates
Table 23. Ceva Sant? Animale Basic Information, Manufacturing Base and Competitors
Table 24. Ceva Sant? Animale Major Business
Table 25. Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 26. Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Ceva Sant? Animale Recent Developments/Updates
Table 28. Harbin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 29. Harbin Pharmaceutical Group Major Business
Table 30. Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 31. Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Harbin Pharmaceutical Group Recent Developments/Updates
Table 33. Qilu Animal Health Products Basic Information, Manufacturing Base and Competitors
Table 34. Qilu Animal Health Products Major Business
Table 35. Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 36. Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Qilu Animal Health Products Recent Developments/Updates
Table 38. Guangdong Winsun Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Guangdong Winsun Bio-Pharmaceutical Major Business
Table 40. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 41. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Guangdong Winsun Bio-Pharmaceutical Recent Developments/Updates
Table 43. Jilin HeYuan Bioengineering Basic Information, Manufacturing Base and Competitors
Table 44. Jilin HeYuan Bioengineering Major Business
Table 45. Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 46. Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Jilin HeYuan Bioengineering Recent Developments/Updates
Table 48. Jofunhwa Biotechnology Basic Information, Manufacturing Base and Competitors
Table 49. Jofunhwa Biotechnology Major Business
Table 50. Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Product and Services
Table 51. Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Jofunhwa Biotechnology Recent Developments/Updates
Table 53. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Swine Mycoplasma Pneumonia Live Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Swine Mycoplasma Pneumonia Live Vaccine Production Site of Key Manufacturer
Table 58. Swine Mycoplasma Pneumonia Live Vaccine Market: Company Product Type Footprint
Table 59. Swine Mycoplasma Pneumonia Live Vaccine Market: Company Product Application Footprint
Table 60. Swine Mycoplasma Pneumonia Live Vaccine New Market Entrants and Barriers to Market Entry
Table 61. Swine Mycoplasma Pneumonia Live Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Swine Mycoplasma Pneumonia Live Vaccine Raw Material
Table 121. Key Manufacturers of Swine Mycoplasma Pneumonia Live Vaccine Raw Materials
Table 122. Swine Mycoplasma Pneumonia Live Vaccine Typical Distributors
Table 123. Swine Mycoplasma Pneumonia Live Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Swine Mycoplasma Pneumonia Live Vaccine Picture
Figure 2. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value Market Share by Type in 2022
Figure 4. 168 Strains Examples
Figure 5. RM48 Strains Examples
Figure 6. Other Examples
Figure 7. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value Market Share by Application in 2022
Figure 9. Piglets Examples
Figure 10. Adult Pigs Examples
Figure 11. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Swine Mycoplasma Pneumonia Live Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Swine Mycoplasma Pneumonia Live Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Swine Mycoplasma Pneumonia Live Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Swine Mycoplasma Pneumonia Live Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Swine Mycoplasma Pneumonia Live Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Swine Mycoplasma Pneumonia Live Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Swine Mycoplasma Pneumonia Live Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Swine Mycoplasma Pneumonia Live Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Swine Mycoplasma Pneumonia Live Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 53. China Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Swine Mycoplasma Pneumonia Live Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Swine Mycoplasma Pneumonia Live Vaccine Market Drivers
Figure 74. Swine Mycoplasma Pneumonia Live Vaccine Market Restraints
Figure 75. Swine Mycoplasma Pneumonia Live Vaccine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Swine Mycoplasma Pneumonia Live Vaccine in 2022
Figure 78. Manufacturing Process Analysis of Swine Mycoplasma Pneumonia Live Vaccine
Figure 79. Swine Mycoplasma Pneumonia Live Vaccine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Swine Mycoplasma Pneumonia Live Vaccine Picture
Figure 2. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value Market Share by Type in 2022
Figure 4. 168 Strains Examples
Figure 5. RM48 Strains Examples
Figure 6. Other Examples
Figure 7. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value Market Share by Application in 2022
Figure 9. Piglets Examples
Figure 10. Adult Pigs Examples
Figure 11. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Swine Mycoplasma Pneumonia Live Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Swine Mycoplasma Pneumonia Live Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Swine Mycoplasma Pneumonia Live Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Swine Mycoplasma Pneumonia Live Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Swine Mycoplasma Pneumonia Live Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Swine Mycoplasma Pneumonia Live Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Swine Mycoplasma Pneumonia Live Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Swine Mycoplasma Pneumonia Live Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Swine Mycoplasma Pneumonia Live Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Swine Mycoplasma Pneumonia Live Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 53. China Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Swine Mycoplasma Pneumonia Live Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Swine Mycoplasma Pneumonia Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Swine Mycoplasma Pneumonia Live Vaccine Market Drivers
Figure 74. Swine Mycoplasma Pneumonia Live Vaccine Market Restraints
Figure 75. Swine Mycoplasma Pneumonia Live Vaccine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Swine Mycoplasma Pneumonia Live Vaccine in 2022
Figure 78. Manufacturing Process Analysis of Swine Mycoplasma Pneumonia Live Vaccine
Figure 79. Swine Mycoplasma Pneumonia Live Vaccine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
